The first patient has been treated in a first-in-human clinical trial investigating the safety and efficacy of the CXLens system, a quantitative corneal cross-linking, or qCXL, technology for ...
Good afternoon, and thank you for joining our fourth quarter and full year 2025 conference call. With me today is our CEO, ...
The March 8th auction includes rare Five Roses, Frontenac, and Sweet Caporal signage, followed by an evening session ...
Joining me are Parth Mehrotra, our Chief Executive Officer, and David Mountcastle, our Chief Financial Officer. Adjusted EBITDA for the year increased 38.8% to $125.5 million, with EBITDA margin as a ...
Background Gut microbiota dysbiosis is linked to autism spectrum disorder (ASD) in children. However, the role of bacterial ...
The Cyclical Nature of Safety Failure: A Multi-Level Grounded Theory Framework for Construction Safety Management in Ghana ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results